Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 2
1989 4
1990 4
1991 8
1992 11
1993 13
1994 19
1995 11
1996 16
1997 10
1998 17
1999 10
2000 8
2001 11
2002 17
2003 12
2004 9
2005 24
2006 11
2007 20
2008 14
2009 26
2010 16
2011 43
2012 44
2013 37
2014 48
2015 99
2016 82
2017 74
2018 113
2019 68
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

826 results
Results by year
Filters applied: . Clear all
Page 1
Direct ELISA.
Lin AV. Lin AV. Methods Mol Biol. 2015;1318:61-7. doi: 10.1007/978-1-4939-2742-5_6. Methods Mol Biol. 2015. PMID: 26160564
Cleavable linkers in antibody-drug conjugates.
Bargh JD , Isidro-Llobet A , Parker JS , Spring DR . Bargh JD , et al. Chem Soc Rev. 2019 Aug 12;48(16):4361-4374. doi: 10.1039/c8cs00676h. Chem Soc Rev. 2019. PMID: 31294429 Review.
Peptide-Drug Conjugate: A Novel Drug Design Approach.
Ma L, Wang C, He Z, Cheng B, Zheng L, Huang K. Ma L, et al. Curr Med Chem. 2017;24(31):3373-3396. doi: 10.2174/0929867324666170404142840. Curr Med Chem. 2017. PMID: 28393694 Review.
Antibody-drug conjugates- stability and formulation.
Duerr C, Friess W. Duerr C, et al. Eur J Pharm Biopharm. 2019 Jun;139:168-176. doi: 10.1016/j.ejpb.2019.03.021. Epub 2019 Mar 30. Eur J Pharm Biopharm. 2019. PMID: 30940541 Review.
Current ADC Linker Chemistry.
Jain N, Smith SW, Ghone S, Tomczuk B. Jain N, et al. Pharm Res. 2015 Nov;32(11):3526-40. doi: 10.1007/s11095-015-1657-7. Epub 2015 Mar 11. Pharm Res. 2015. PMID: 25759187 Free PMC article. Review.
Linker technologies for antibody-drug conjugates.
Nolting B. Nolting B. Methods Mol Biol. 2013;1045:71-100. doi: 10.1007/978-1-62703-541-5_5. Methods Mol Biol. 2013. PMID: 23913142 Review.
826 results
Jump to page
Feedback